<DOC>
	<DOCNO>NCT01502774</DOCNO>
	<brief_summary>Infarct size major determinant prognosis Acute Myocardial Infarction ( AMI ) . The investigator recently report cyclosporine A , administer immediately prior percutaneous coronary intervention ( PCI ) , significantly reduce infarct size STEMI ( ST Elevation acute Myocardial Infarction ) patient . The objective present study determine whether cyclosporine improve STEMI patient clinical outcome . Nine-hundred seventy two patient ST elevation MI enter multicentre , randomize , placebo-controlled , double-blinded study . They receive one single injection cyclosporine A ( CicloMulsion , verum ) equivalent volume placebo prior reperfusion therapy PCI . The incidence combine endpoint ( mortality , hospitalization heart failure , leave ventricular ( LV ) remodel ) assess one year three year treatment .</brief_summary>
	<brief_title>Cyclosporine Prognosis Acute Myocardial Infarction ( MI ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Eligibility criterion ( screen hospital admission ) : 1 . All ( male female ) patient , age 18 , without legal protection measure , 2 . Having health coverage , 3 . Presenting within 12 hour onset chest pain , 4. Who ST segment elevation ≥0.2 mV two contiguous lead , 5 . For clinical decision make treat percutaneous coronary intervention ( PCI ) . And ( inclusion criterion confirm admission coronaryangiography ) : 6 . The culprit coronary artery LAD 7 . The LAD artery occlude ( TIMI flow grade 01 ) time admission coronary angiography . 8 . Preliminary oral inform consent follow sign informed consent soon possible . Patients undergo either primary PCI rescue PCI eligible study . Patients previous AMI , PCI coronary artery bypass surgery ( CABG ) eligible study . 1 . Patients loss consciousness confuse 2 . Patients cardiogenic shock 3 . Patients leave circumflex right coronary artery ( RCA ) culprit artery , evidence coronary collateral risk region 4 . Patients open ( TIMI &gt; 1 ) LAD coronary artery admission initial ( admission ) coronary angiography 5 . Patients 5.2. know hypersensitivity cyclosporine 5.3. know hypersensitivity egg , peanut Soyabean proteins 5.4. know renal insufficiency ( either know creatinin clearance &lt; 30 ml/min/1.73m² current medical care severe renal insufficiency ) 5.5. know liver insufficiency 5.6. uncontrolled ( treat untreated ) hypertension ( &gt; 180/110 mmHg ) 6 . Patients treat compound contain Hypericum perforatum ( St.John'sworth ) Stiripentol Aliskiren Bosentan Rosuvastatine 7 . Female patient currently pregnant woman childbearing age use contraception ( oral diagnosis ) . 8 . Patients disorder associate immunological dysfunction recently 6 month prior presentation 8.2. cancer , lymphoma 8.3. know positive serology HIV , hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>STEMI</keyword>
	<keyword>cyclosporine</keyword>
	<keyword>reperfusion injury</keyword>
</DOC>